SIBO prevalence was 37.6% in obese children vs. 3.3% in controls. SIBO-positive obese children had a significantly higher NAFLD prevalence (59.5% vs. 10.2%) and more frequent elevated ALT/AST, hypertension, and metabolic syndrome. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.